cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Oncternal Therapeutics Inc
6 own
21 watching
Current Price
$1.18
$0.02
(1.58%)
logo-onct
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
65.42M
52-Week High
52-Week High
2.2
52-Week Low
52-Week Low
0.6902
Average Volume
Average Volume
0.09M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization65.42M
icon52-Week High2.2
icon52-Week Low0.6902
iconAverage Volume0.09M
iconDividend Yield--
iconP/E Ratio--
What does the Oncternal Therapeutics Inc do?
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company s clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.
Read More
How much money does Oncternal Therapeutics Inc make?
News & Events about Oncternal Therapeutics Inc.
Globe Newswire
2 months ago
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that interim clinical data from the ongoing Phase 1/2 Study CIRM-0001 will be presented in an ...
Globe Newswire
4 months ago
SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the initiation of its Phase 3 global registrational study of zilovertamab, ZILO-301 (...
Globe Newswire
4 months ago
SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that management will participate in the Cantor Oncology, Hematology & HemeOnc Conference on ...
PR Newswire
7 months ago
Thinking about buying stock in Redbox, New Oriental Education, Day One Biopharmaceuticals, Exicure, or Oncternal Therapeutics? Thinking about buying stock in Redbox, New Oriental Education, Day One Biopharmaceuticals, Exicure, or Oncternal Therapeutics? PR Newswire NEW YORK, June 13, 2022 NEW YORK...
Globe Newswire
7 months ago
SAN DIEGO, June 10, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that the rationale and plans for its upcoming Phase 3 ZILO-301 (zilovertamab plus ibrutinib ...
Frequently Asked Questions
Frequently Asked Questions
What is Oncternal Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Oncternal Therapeutics Inc shares?
plus_minus_icon
How can I buy Oncternal Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Oncternal Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Oncternal Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Oncternal Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Oncternal Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Oncternal Therapeutics Inc?
plus_minus_icon
What percentage is Oncternal Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Oncternal Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.18
$0.02
(1.58%)
logo-onct
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00